At 28 weeks, berobenatide demonstrated dose-dependent decreases in A1C up to 2.2% and in body weight of up to 10.2% with a slope that continued to decrease weekly, said Ildiko Lingvay, MD, MPH, MSCS, Professor in the Department of Internal Medicine, University of Texas Southwestern Medical Center
doi: 10.17305/bjbms.2022.7348 90 MaCSolitanoVDaneseSJairathV
2014;306:E13781387
Many women say they feel more energized, happier, able to concentrate better, and notice more effective fat-burning while exercising or managing a full schedule
These are reversible upon discontinuation
In addition to weight loss, people taking semaglutide may experience significant improvements in their cholesterol, blood pressure, blood sugar levels, and heart disease risk